GCTK — Glucotrack, Inc.

—
OTC · Health Care · Health Care Equipment & Supplies · CIK 1506983 ·
Last close
$0.19
Market Cap
$149.3K
52W High
$207.00
52W Low
$0.19
ADV30
2,512,791
Next earnings
—

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Jun 2026 0 — -3,400,000 -3,814,000 1,495,000 1,124,000 3,236,000
Mar 2026 0 — -4,203,000 -4,334,000 4,356,000 3,929,000 5,207,000
Dec 2025 0 — -3,487,000 -3,628,000 7,838,000 7,383,000 5,010,000
Sep 2025 0 — -4,309,000 -4,171,000 8,290,000 7,869,000 5,539,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-16,221,000
Investing CF
$-87,000
Financing CF
$7,882,000
CapEx
$-96,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-17.67
As of
2026-11-15

Balance + Analyst (yfinance extras)

Retained Earnings
$-159,986,000
Inventory
—
Receivables
—
ST Investments
—
EBIT TTM
$-15,399,000
Pretax Income TTM
$-15,947,000
Interest Exp TTM
—
Analysts
—

Annual Trend (SEC EDGAR, last 5y)

Revenues vs Net Income (last 5y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 0 -16,090,000 -19,388,000 7,838,000 5,010,000 2,828,000 -15,240,000
Dec 2024 0 -14,547,000 -22,597,000 5,932,000 18,932,000 -13,000,000 -12,490,000
Dec 2023 0 -7,104,000 -7,097,000 4,905,000 1,708,000 3,197,000 -6,558,000
Dec 2022 0 -4,432,000 -4,435,000 2,438,000 1,208,000 1,230,000 -3,729,000
Dec 2021 — — — — — — —

TTM Snapshot

Revenues TTM
$30,798,000
NetIncome TTM
$15,947,000
OpCashFlow TTM
—
Assets (Latest)
$1,495,000
Forward EPS
—

Peers — same industry

TickerNameMarket CapLastDaily %
SIGY Sigyn Therapeutics, Inc. $145.2K $0.03 —
PFSA Profusa, Inc. $210.8K $0.35 —
FEED ENvue Medical, Inc. $235.5K $0.25 —
PREM Premier Air Charter Holdings Inc. $393.6K $0.01 —
ODYY Odyssey Health, Inc. $771.5K $0.01 —

News headlines (Yahoo Finance, 1h cache)

Glucotrack, Inc. Announces Reverse Stock Split
2026-10-22 13:00 · Yahoo
Qare™ Is Here: Lōkahi Therapeutics™ Launches a Proprietary New Way to Compare Your Care, Beginning with GLP-1 Medications
2026-10-14 13:00 · Yahoo
Lōkahi Therapeutics™ Expands University of Georgia Collaboration Through First International ai² Pipeline™ Project with Universität Paderborn
2026-10-01 21:15 · Yahoo
Lōkahi Therapeutics™ Announces Qare™, the First Real-Time Comparative Health Platform for GLP-1 Medications, with Public Availability Beginning October 14
2026-09-30 13:00 · Yahoo
Lōkahi Therapeutics™ Expands ai2 Pipeline™ Program Through Collaboration with Pepperdine E2B™
2026-09-25 13:00 · Yahoo
Glucotrack, Inc. Announces Pricing of $3 Million Public Offering
2026-09-24 12:45 · Yahoo
Lōkahi Therapeutics™ Advances its Proprietary ai² PIPELINE (formerly ai² Futures Lab) Process from Internal Asset Engine to Revenue-Generating Platform
2026-09-23 20:30 · Yahoo
Glucotrack Announces $11.5 Million Financing
2026-09-11 12:00 · Yahoo
Lōkahi Therapeutics™ Expands ai² Futures Lab™ Asset Origination Network Through Collaboration with San Diego State University Fowler College of Business
2026-09-02 13:15 · Yahoo
Lōkahi Therapeutics™ Initiates Clinical Trial Manufacturing for LT-100
2026-08-25 12:00 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.